NASDAQ:AMTX Aemetis (AMTX) Stock Forecast, Price & News $4.92 -0.28 (-5.38%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$4.74▼$5.3550-Day Range$1.73▼$5.2052-Week Range$1.16▼$11.50Volume1.07 million shsAverage Volume839,771 shsMarket Capitalization$180.51 millionP/E RatioN/ADividend YieldN/APrice Target$12.09 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Aemetis MarketRank™ ForecastAnalyst RatingHold2.33 Rating ScoreUpside/Downside145.8% Upside$12.09 Price TargetShort InterestHealthy17.93% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.78Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.22) to ($0.19) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.01 out of 5 starsOils/Energy Sector185th out of 245 stocksIndustrial Organic Chemicals Industry10th out of 20 stocks 3.2 Analyst's Opinion Consensus RatingAemetis has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 3 buy ratings, 2 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.09, Aemetis has a forecasted upside of 145.8% from its current price of $4.92.Amount of Analyst CoverageAemetis has only been the subject of 2 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted17.93% of the outstanding shares of Aemetis have been sold short.Short Interest Ratio / Days to CoverAemetis has a short interest ratio ("days to cover") of 6.8.Change versus previous monthShort interest in Aemetis has recently decreased by 13.76%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAemetis does not currently pay a dividend.Dividend GrowthAemetis does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AMTX. Previous Next 2.7 News and Social Media Coverage News SentimentAemetis has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Oils/Energy companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Aemetis this week, compared to 3 articles on an average week.Search InterestOnly 11 people have searched for AMTX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows3 people have added Aemetis to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aemetis insiders have not sold or bought any company stock.Percentage Held by Insiders14.34% of the stock of Aemetis is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions50.72% of the stock of Aemetis is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Aemetis are expected to grow in the coming year, from ($1.22) to ($0.19) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aemetis is -1.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aemetis is -1.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Aemetis (NASDAQ:AMTX) StockAemetis, Inc. is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. It operates through the North America and India geographical segments. The North America segment manages Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, California, the Goodland Plant, Kansas and the research and development facility in Minnesota. The India segment refers to the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2006 and is headquartered in Cupertino, CA.Read More Receive AMTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter. Email Address AMTX Stock News HeadlinesJune 1, 2023 | fool.comAemetis (NASDAQ: AMTX)May 29, 2023 | americanbankingnews.comAemetis, Inc. (NASDAQ:AMTX) Short Interest Down 13.8% in MayJune 3, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.May 25, 2023 | finance.yahoo.comAemetis Resumes Operations at 65 MGY California Biofuel Plant After Completing Extensive Maintenance and UpgradesMay 22, 2023 | americanbankingnews.comAemetis (NASDAQ:AMTX) Price Target Increased to $9.80 by Analysts at Stifel NicolausMay 21, 2023 | finance.yahoo.comGrowth Investors: Industry Analysts Just Upgraded Their Aemetis, Inc. (NASDAQ:AMTX) Revenue Forecasts By 12%May 18, 2023 | msn.comAemetis RNG production plant receives EPA approval for D3 RIN generationMay 18, 2023 | finance.yahoo.comAemetis RNG Production Facility Receives EPA Approval for D3 RIN Generation; LCFS Data Collection Completed and Pathway Review In Process at CARB; Six Dairy Digesters Fully OperationalJune 3, 2023 | Stocks To Trade (Ad)Free SMS Trade Alerts. Up to 15 opportunities a day.Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 18, 2023 | americanbankingnews.comAnalysts Set Aemetis, Inc. (NASDAQ:AMTX) Price Target at $11.96May 4, 2023 | finance.yahoo.comAemetis Reports First Quarter 2023 Financial ResultsMay 3, 2023 | americanbankingnews.comAemetis, Inc. (NASDAQ:AMTX) Short Interest UpdateMay 1, 2023 | finance.yahoo.comAemetis to Review First Quarter 2023 Financial Results on May 4, 2023May 1, 2023 | americanbankingnews.comAemetis (NASDAQ:AMTX) Price Target Cut to $9.00April 25, 2023 | finance.yahoo.comStonegate Capital Partners Updates Coverage on Aemetis, Inc. (AMTX) Q4 2022April 23, 2023 | americanbankingnews.comAemetis, Inc. (NASDAQ:AMTX) Receives Consensus Recommendation of "Hold" from AnalystsApril 17, 2023 | msn.comAemetis secures $34M contract to supply biodiesel from its Kakinada plant to Indian OMCsApril 17, 2023 | msn.comAemetis Secures $34M In Biodiesel Contracts From India Oil RefinersApril 17, 2023 | finance.yahoo.comAemetis Awarded $34 Million of Biodiesel Contracts by India Oil Refiners for Delivery in Q2 2023April 17, 2023 | finance.yahoo.comNot Many Are Piling Into Aemetis, Inc. (NASDAQ:AMTX) Just YetApril 15, 2023 | msn.comStifel Maintains Aemetis (AMTX) Buy RecommendationApril 15, 2023 | americanbankingnews.comAemetis (NASDAQ:AMTX) Price Target Cut to $10.00 by Analysts at Stifel NicolausApril 14, 2023 | markets.businessinsider.comWhere Aemetis Stands With AnalystsApril 14, 2023 | americanbankingnews.comAemetis (NASDAQ:AMTX) Given New $2.50 Price Target at Truist FinancialApril 13, 2023 | msn.comTruist Securities Maintains Aemetis (AMTX) Hold RecommendationApril 12, 2023 | seekingalpha.comStaying Away From Aemetis And Exposure To Another NameApril 3, 2023 | americanbankingnews.comAemetis, Inc. (NASDAQ:AMTX) Sees Large Growth in Short InterestSee More Headlines AMTX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMTX Company Calendar Last Earnings3/09/2023Today6/03/2023Next Earnings (Estimated)8/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Industrial organic chemicals Sub-IndustryN/A SectorOils/Energy Current SymbolNASDAQ:AMTX CUSIPN/A CIK738214 Webwww.aemetis.com Phone(408) 213-0940Fax408-252-8044Employees158Year FoundedN/APrice Target and Rating Average Stock Price Forecast$12.09 High Stock Price Forecast$27.00 Low Stock Price Forecast$2.50 Forecasted Upside/Downside+145.8%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($3.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-107,760,000.00 Net Margins-57.53% Pretax Margin-55.70% Return on EquityN/A Return on Assets-33.41% Debt Debt-to-Equity RatioN/A Current Ratio0.20 Quick Ratio0.08 Sales & Book Value Annual Sales$256.51 million Price / Sales0.70 Cash FlowN/A Price / Cash FlowN/A Book Value($6.06) per share Price / Book-0.81Miscellaneous Outstanding Shares36,690,000Free Float31,429,000Market Cap$180.51 million OptionableNot Optionable Beta1.14 Key ExecutivesEric Armstrong McAfeeChairman & Chief Executive OfficerTodd A. WaltzChief Financial Officer, Secretary & Executive VPAndrew B. FosterExecutive VP & President-Advanced Fuels BusinessSanjeev GuptaExecutive President-Aemetis InternationalKey CompetitorsCENAQ EnergyNASDAQ:CENQGevoNASDAQ:GEVOVerde Clean FuelsNASDAQ:VGASFutureFuelNYSE:FFREX American ResourcesNYSE:REXView All CompetitorsInstitutional OwnershipJPMorgan Chase & Co.Bought 6,095 shares on 5/18/2023Ownership: 0.072%State Street CorpBought 48,501 shares on 5/16/2023Ownership: 1.817%Geode Capital Management LLCBought 8,288 shares on 5/16/2023Ownership: 1.613%Susquehanna International Group LLPSold 82,400 shares on 5/16/2023Ownership: 0.000%Jane Street Group LLCSold 23,106 shares on 5/16/2023Ownership: 0.051%View All Institutional Transactions AMTX Stock - Frequently Asked Questions Should I buy or sell Aemetis stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aemetis in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AMTX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AMTX, but not buy additional shares or sell existing shares. View AMTX analyst ratings or view top-rated stocks. What is Aemetis' stock price forecast for 2023? 6 brokerages have issued 12-month price objectives for Aemetis' shares. Their AMTX share price forecasts range from $2.50 to $27.00. On average, they predict the company's stock price to reach $12.09 in the next year. This suggests a possible upside of 145.8% from the stock's current price. View analysts price targets for AMTX or view top-rated stocks among Wall Street analysts. How have AMTX shares performed in 2023? Aemetis' stock was trading at $3.96 on January 1st, 2023. Since then, AMTX shares have increased by 24.2% and is now trading at $4.92. View the best growth stocks for 2023 here. Are investors shorting Aemetis? Aemetis saw a drop in short interest in May. As of May 15th, there was short interest totaling 6,580,000 shares, a drop of 13.8% from the April 30th total of 7,630,000 shares. Based on an average trading volume of 971,100 shares, the short-interest ratio is presently 6.8 days. View Aemetis' Short Interest. When is Aemetis' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our AMTX earnings forecast. How were Aemetis' earnings last quarter? Aemetis, Inc. (NASDAQ:AMTX) announced its earnings results on Thursday, March, 9th. The specialty chemicals company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.29. The specialty chemicals company earned $66.73 million during the quarter, compared to analyst estimates of $74.82 million. What ETFs hold Aemetis' stock? ETFs with the largest weight of Aemetis (NASDAQ:AMTX) stock in their portfolio include Strategy Shares Halt Climate Change ETF (NZRO). What other stocks do shareholders of Aemetis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aemetis investors own include Pennsylvania Real Estate Investment Trust (PEI), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Tilly's (TLYS), Auxly Cannabis Group (CBWTF), Novan (NOVN), Aeterna Zentaris (AEZS), American Cannabis (AMMJ) and Bionano Genomics (BNGO). What is Aemetis' stock symbol? Aemetis trades on the NASDAQ under the ticker symbol "AMTX." Who are Aemetis' major shareholders? Aemetis' stock is owned by many different institutional and retail investors. Top institutional investors include Grantham Mayo Van Otterloo & Co. LLC (5.82%), State Street Corp (1.82%), Geode Capital Management LLC (1.61%), Stifel Financial Corp (1.24%), CIBC Private Wealth Group LLC (0.69%) and Renaissance Technologies LLC (0.23%). Insiders that own company stock include Andrew B Foster, Andrew B Foster, Francis P Barton, Francis P Barton, John R Block, John R Block, Sanjeev Gupta, Timothy Alan Simon and Todd Waltz. View institutional ownership trends. How do I buy shares of Aemetis? Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Aemetis' stock price today? One share of AMTX stock can currently be purchased for approximately $4.92. How much money does Aemetis make? Aemetis (NASDAQ:AMTX) has a market capitalization of $180.51 million and generates $256.51 million in revenue each year. The specialty chemicals company earns $-107,760,000.00 in net income (profit) each year or ($3.38) on an earnings per share basis. How many employees does Aemetis have? The company employs 158 workers across the globe. How can I contact Aemetis? Aemetis' mailing address is 20400 STEVENS CREEK BLVD SUITE 700, CUPERTINO CA, 95014. The official website for the company is www.aemetis.com. The specialty chemicals company can be reached via phone at (408) 213-0940, via email at investors@aemetis.com, or via fax at 408-252-8044. This page (NASDAQ:AMTX) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aemetis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.